The growing demand for controlled immunological study and therapeutic development has spurred significant advances in recombinant growth factor manufacture. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently produced using diverse expression methods, including bacterial hosts, higher cell lines, and viral expre